Thermo Fisher Scientific (TMO) : Agf Investments America reduced its stake in Thermo Fisher Scientific by 1.72% during the most recent quarter end. The investment management company now holds a total of 71,500 shares of Thermo Fisher Scientific which is valued at $10,508,355 after selling 1,250 shares in Thermo Fisher Scientific , the firm said in a disclosure report filed with the SEC on May 2, 2016.Thermo Fisher Scientific makes up approximately 7.66% of Agf Investments America’s portfolio.
Thermo Fisher Scientific opened for trading at $145 and hit $147.53 on the upside on Friday, eventually ending the session at $146.97, with a gain of 1.26% or 1.83 points. The heightened volatility saw the trading volume jump to 12,57,404 shares. Company has a market cap of $58,239 M.
Other Hedge Funds, Including , Agf Investments reduced its stake in TMO by selling 3,158 shares or 17.05% in the most recent quarter. The Hedge Fund company now holds 15,366 shares of TMO which is valued at $2,258,341. Thermo Fisher Scientific makes up approx 0.03% of Agf Investments’s portfolio.Public Employees Retirement Association Of Colorado boosted its stake in TMO in the latest quarter, The investment management firm added 22,197 additional shares and now holds a total of 440,407 shares of Thermo Fisher Scientific which is valued at $63,528,710. Thermo Fisher Scientific makes up approx 0.52% of Public Employees Retirement Association Of Colorado’s portfolio.Great West Life Assurance Co Can reduced its stake in TMO by selling 118,601 shares or 28.09% in the most recent quarter. The Hedge Fund company now holds 303,610 shares of TMO which is valued at $43,795,743. Thermo Fisher Scientific makes up approx 0.16% of Great West Life Assurance Co Can’s portfolio.Dumont Blake Investment Advisors reduced its stake in TMO by selling 107 shares or 1.81% in the most recent quarter. The Hedge Fund company now holds 5,796 shares of TMO which is valued at $851,143. Thermo Fisher Scientific makes up approx 0.44% of Dumont Blake Investment Advisors’s portfolio.
On the company’s financial health, Thermo Fisher Scientific reported $1.80 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $1.74. The company had revenue of $4294.80 million for the quarter, compared to analysts expectations of $4113.28 million. The company’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.63 EPS.
Many Wall Street Analysts have commented on Thermo Fisher Scientific. Company shares were Reiterated by Mizuho on May 3, 2016 to “Buy”, Firm has raised the Price Target to $ 163 from a previous price target of $160 .Thermo Fisher Scientific was Downgraded by Jefferies to ” Hold” on Apr 29, 2016. Company shares were Reiterated by Mizuho on Apr 4, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $150 .
Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.